A team from Cambridge identified a ‘signature’ in the blood which may help identify why some patients respond better to vaccines than others and who should be prioritised
READ SOURCE
A team from Cambridge identified a ‘signature’ in the blood which may help identify why some patients respond better to vaccines than others and who should be prioritised
READ SOURCE
This website uses cookies. By continuing to use this site, you accept our use of cookies.